Immune Checkpoint Co-blockade of CD47 and HLA Class I Receptors to increase CD20 Antibody-mediated Phagocytosis of Lymphoma Cells

Zeller T, Lutz S, Munnich IA, Windisch R, Hilger P, Herold T, Tahiri N, Banck JC, Weigert O, Moosmann A, Von Bergwelt-Baildon M, Bruns H, Wichmann C, Valerius T, Schewe DM, Peipp M, Roesner T, Humpe A, Kellner C (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 162-162

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Heiko Bruns Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Deutsches Konsortium für Translationale Krebsforschung (DKTK) DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Otto-von-Guericke-Universität Magdeburg DE Germany (DE)

How to cite

APA:

Zeller, T., Lutz, S., Munnich, I.A., Windisch, R., Hilger, P., Herold, T.,... Kellner, C. (2022). Immune Checkpoint Co-blockade of CD47 and HLA Class I Receptors to increase CD20 Antibody-mediated Phagocytosis of Lymphoma Cells. In ONCOLOGY RESEARCH AND TREATMENT (pp. 162-162). BASEL: KARGER.

MLA:

Zeller, T., et al. "Immune Checkpoint Co-blockade of CD47 and HLA Class I Receptors to increase CD20 Antibody-mediated Phagocytosis of Lymphoma Cells." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 162-162.

BibTeX: Download